menu search

ZyVersa Therapeutics’ CEO, Stephen C. Glover, to Participate in A.G.P.’s Virtual Healthcare Conference

ZyVersa Therapeutics’ CEO, Stephen C. Glover, to Participate in A.G.P.’s Virtual Healthcare Conference
ZyVersa is advancing a dynamic pipeline of drug candidates with multiple programs built around two proprietary technologies – Cholesterol Efflux Mediator™ VAR 200 for treatment of kidney diseases, and Inflammasome ASC Inhibitor IC 100 for treatment of multiple CNS and other inflammatory diseases Mr. Glover welcomes one-on-one meetings with registered investors to discuss ZyVersa’s technology, […] The post ZyVersa Therapeutics’ CEO, Stephen C. Glover, to Participate in A.G.P.’s Virtual Healthcare... Read More
Posted: May 11 2023, 13:07
Author Name: forextv
Views: 101912

Search within

Pages Search Results: